Cargando…
Rivaroxaban versus low-molecular weight heparin plus warfarin prevents portal vein system thrombosis after splenectomy and pericardial devascularization: A randomized clinical trial
This study aimed to evaluate the safety and efficacy of rivaroxaban in preventing portal vein system thrombosis (PVST) in patients with liver cirrhosis after splenectomy and pericardial devascularization. 70 cirrhotic patients undergoing splenectomy and pericardial devascularization were randomly as...
Autores principales: | Yao, Wei, Feng, Yongan, Liu, Ting, Li, Wujun, Zhang, Mei, Yao, Yingmin, Wu, Shengli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056059/ https://www.ncbi.nlm.nih.gov/pubmed/33883982 http://dx.doi.org/10.17179/excli2020-3120 |
Ejemplares similares
-
A novel method detecting the key clinic factors of portal vein system thrombosis of splenectomy & cardia devascularization patients for cirrhosis & portal hypertension
por: Wang, Mingzhao, et al.
Publicado: (2019) -
The therapeutic effect of splenectomy plus selective pericardial devascularization versus conventional pericardial devascularization on portal hypertension in China: a meta-analysis
por: Zhao, Yajie, et al.
Publicado: (2018) -
Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
por: Li, Yongning, et al.
Publicado: (2022) -
Spleen bed laparoscopic splenectomy plus pericardial devascularization for elderly patients with portal hypertension
por: Yan, Cao, et al.
Publicado: (2022) -
Risk Factors for a High Comprehensive Complication Index after Splenectomy Plus Pericardial Devascularization for Portal Hypertension
por: Zhang, Yafei, et al.
Publicado: (2023)